Happify Health is launching its first prescription digital therapeutic (PDTx), called Ensemble, which will focus on treating Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD).
Happify Health has launched a digital therapeutic designed to help diagnose and manage major depressive disorder as well as generalized anxiety disorder, as the two conditions often go hand-in-hand.
NEW YORK--(BUSINESS WIRE)--Today, Happify Health (www.HappifyHealth.com), the Intelligent Healing Company, announced findings from a real-world data analysis exploring the impact of Happify for users ...
Axios' Erin Brodwin published a new investigation which discovered healthcare automation startup Olive is exaggerating its capabilities and only uses "rough estimations" to gauge its cost savings.
Happify Inc. launched Ensemble, a prescription digital therapy designed to treat patients with major depressive disorder (MDD) or generalized anxiety disorder (GAD). The app joins several others that ...
After the Food and Drug Administration loosened guidelines last year for digital health products treating some behavioral health conditions, startup Happify Health is making an app-based treatment for ...
Happify Inc. launched Ensemble, a prescription digital therapy designed to treat patients with major depressive disorder (MDD) or generalized anxiety disorder (GAD). The app joins several others that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results